GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

UltraGreen.ai ULG.SI · SGD

Health Care · SGX · 🇸🇬 Singapore

Compare

0.39

-7.23%

Close of 6 Nov 2026, in SGD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About UltraGreen.ai

Its shares trade on SGX under the ticker ULG.SI. It has been listed since 3 December 2025. In the fiscal year to 31 December 2025, it reported revenue of $137.9m and net income of $75.6m. At that date it held total assets of $335.6m and shareholders' equity of $310.6m.

UltraGreen.ai Ltd is a SG-based company operating in Health Care Equipment & Supplies industry. UltraGreen.ai Ltd is a fluorescence-guided surgery, advancing the use of indocyanine green (ICG) and imaging systems to help improve surgical precision and patient outcomes. The Company’s products include ICG (IC-GREEN, Verdye, Indocyanine Green for Injection), IC-Flow Imaging System, PerfusionWorks Quantification Software, and UltraGreen Data Systems. The IC-Flow Imaging System is an open near-infrared (NIR) fluorescence imaging camera designed to deliver clear real-time visualization of IC-GREEN / Veryde (indocyanine green, ICG) during open surgical procedures. Its UltraGreen Data Systems delivers a cloud-based platform to capture, analyze and report surgical quantification data. Its cardiac data platform integrates advanced biosensors, patient-friendly monitoring, and artificial intelligence (AI)-driven analysis to deliver continuous cardiac insights with clinical reliability. Its UbiqVue Holter is a cloud-based end-to-end ECG monitoring and Holter reporting solution.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
3 Dec 2025

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company operates in the Health Care sector with specialized equipment.
  • It offers fluorescence-guided surgery systems using indocyanine green.
  • Cloud-based platforms provide AI-driven cardiac insights and data analysis.

Weaknesses

  • The company's city location is listed as unknown.
  • Specific financial performance metrics are not provided in the source.
  • Reliance on untrusted source descriptions limits verified operational details.

Opportunities

  • The IPO is scheduled for December 3, 2025, allowing future capital raising.
  • Expanding the use of ICG imaging can improve surgical precision.
  • Integration of biosensors offers continuous patient monitoring capabilities.

Threats

  • The source material is explicitly treated as untrusted facts.
  • Regulatory changes in the Health Care Equipment industry may impact sales.
  • Competition from other fluorescence imaging system providers exists.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.